Healthcare & Life Sciences
Replace Therapeutics
Replace Therapeutics is a Healthcare & Life Sciences startup based in All, most recent round Series C+, 2 tracked investors.
stubseries-c-plus
series-c-plus
Stage
2023
Founded
2
Investors
About Replace Therapeutics
Replace Therapeutics is a startup founded in 2023 based in All. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Less than a month after launching with $213 million in funding, gene editing company Tome Biosciences has acquired a tiny Californian startup called Replace Therapeutics to expand ...
Explore Replace Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.